Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping. - Wikidata - wikimedia - TriplyDB

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

http://www.wikidata.org/entity/Q37114899

about

Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer Non-invasive approaches to monitor EGFR-TKI treatment in non-small-cell lung cancer Emerging technologies for salivaomics in cancer detection Circulating tumor cells versus circulating tumor DNA in lung cancer-which one will win?Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer Liquid biopsy genotyping in lung cancer: ready for clinical utility?KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.The mutation rates of EGFR in non-small cell lung cancer and KRAS in colorectal cancer of Chinese patients as detected by pyrosequencing using a novel dispensation order.Circulating Cell-Free Tumour DNA in the Management of Cancer.The Emergent Landscape of Detecting EGFR Mutations Using Circulating Tumor DNA in Lung Cancer.Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the disease EGFR Mutation Analysis of Circulating Tumor DNA Using an Improved PNA-LNA PCR Clamp Method Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing Circulating tumor DNA detection in lung cancer patients before and after surgery Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR-tyrosine kinase inhibitor treatment response.Detection of circulating tumor DNA in patients with advanced non-small cell lung cancer.Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis Role of Circulating Cell-Free DNA in Cancers.Molecular pathology in real time.Versatility of peptide nucleic acids (PNAs): role in chemical biology, drug discovery, and origins of life.Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability.Liquid Biopsy in Non-Small Cell Lung Cancer.Comparison of the Amplification Refractory Mutation System, Super Amplification Refractory Mutation System, and Droplet Digital PCR for T790 M Mutation Detection in Non-small Cell Lung Cancer after Failure of Tyrosine Kinase Inhibitor Treatment.Circulating cell-free DNA has a high degree of specificity to detect exon 19 deletions and the single-point substitution mutation L858R in non-small cell lung cancer.The detection and significance of EGFR and BRAF in cell-free DNA of peripheral blood in NSCLC.The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?Detection of activating and acquired resistant mutation in plasma from EGFR-mutated NSCLC patients by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve analysis Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System?Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer.An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.Circulating tumour DNA in EGFR-mutant non-small-cell lung cancer.Liquid Biopsy as Surrogate to Tissue in Lung Cancer for Molecular Profiling: A Meta-Analysis Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management

P2860

Q26775376-A28899AD-42B4-4AFB-B2A6-E1289856DCD4 Q26801357-F1793C68-2730-4175-BBFC-06BC3D5DB54E Q28069566-3FB5DAFF-DCC4-4427-923E-C6902DBF3BA6 Q28077340-9F94986A-6032-436B-B70F-F7E3D2663DD0 Q28082499-D147809B-586F-48E9-AF9B-B0E275C2CDA1 Q33567037-0C7D3C54-77DB-4DED-ABE3-EB6FFFA9352E Q34748747-562DACF6-0940-482E-9580-F05D6DBB604F Q35782746-8F5C71AF-CF05-49FC-8BE1-925722ED34B4 Q35814162-D893EED7-3794-4D9F-8207-570B229319BC Q36095650-D6FFB526-3327-42D8-BF1D-88A4164C34AC Q36834331-CAF74F1C-1B77-4B8E-A81C-A70059BCCB8E Q37127926-5ECE1971-DC6A-4EDE-BC7F-EE0DFC3A8797 Q37198902-64E47AC0-825C-493E-8BDA-8357D8061F63 Q37264643-1B305245-378C-4F9C-B6CC-CAB6CB468FE9 Q37389601-314D579B-7656-4704-ACFA-3905C2AF5C85 Q37709234-23C0FFA9-F095-418E-A060-5A2E12FA2FEB Q37743832-DEB22ADD-6E09-4F8E-96B8-029A1C93E620 Q38591963-1BCF90D3-A142-4B8E-93B3-6F34AEDDEA1C Q38756841-19D061FD-56B0-49EB-BDCC-64EA5C04EEFD Q38834594-44C8C21A-F574-48F7-8F14-FCF2DD3DB97D Q38844281-30489AE3-4B6E-493F-B295-5D9B5BA71D0C Q38881938-BF400821-99C6-4D8B-94BD-1DAC60051E88 Q39076207-995B3476-E894-43AB-B11E-A4BAA0442C50 Q40502030-86BBE625-2BAE-40E2-8631-488FFEA813AC Q41260159-1960291E-C03C-4DC0-AE26-D4BB8A9FA3D0 Q41472736-FCB60481-3E68-41B5-8A85-3A4CB37545B2 Q41866575-888B0017-CD42-4BF6-ABEA-5F1CD4DAE0B3 Q42371507-54F79927-3E8E-45AF-970F-6926F70B3081 Q42835050-87D738AF-F5B5-4D58-B22F-0B1259AFF97E Q47162466-4AC61A34-1D8A-428F-B869-A37F5DF37002 Q47563363-1E0E95FC-788D-4468-84E8-F697C4F8C61F Q48502619-CCDA4FEB-52BD-4C53-B0DE-37D41155B6B1 Q49667322-EF248288-FE31-48D3-BB26-1FA4A4BB7480 Q49887989-A8F1E03C-8CD9-46F6-A752-342E7A937391 Q55282794-DC82C588-44EA-48B9-8117-142C6939C8B6 Q57147737-2856A77F-EF89-4E97-A7BB-D969F30F43F2 Q58578019-FDCB52E1-02CD-4560-841B-245E00EEBFDA

P2860

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

http://www.wikidata.org/entity/Q37114899

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@en

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@nl

type

label

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@en

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@nl

prefLabel

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@en

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@nl

P1433

Q37114899-AA05CE8D-2FF2-496B-868F-8A2E5054E71C

P1476

Q37114899-8047AE4D-0FD4-4386-9F13-35F28CBD38AC

P2093

Q37114899-166FC87A-53F1-4692-9288-D98CE0DC34F3

Q37114899-1B73E62A-49F0-4D38-9E62-53B91D9F915E

Q37114899-20542D39-5CEA-468B-8DC8-E67BFE4C8E20

Q37114899-29105967-F1BB-42A8-8A43-E66BCAE0BCFB

Q37114899-74DA5796-9B50-4C7B-8A67-218066E7BFE6

Q37114899-78257D79-6CC8-40BC-9318-A437C27658C2

Q37114899-94211364-82A3-4CD9-92B9-EBC9F601D8CA

Q37114899-9A93EB98-B88E-455F-8BA8-69A906A5CD41

Q37114899-A9DF6204-E1B5-4E07-BFB5-A847A2A04142

Q37114899-AB74C172-D0FA-4FE2-96D3-5E84D8E6E132

P2860

Q37114899-027A5D78-BB95-4D79-9295-7D2A04F5A2D1

Q37114899-0B02CBEC-8FFA-4B76-AA4D-1A6F3FD426A1

Q37114899-27EA9CAF-4570-4E4D-991F-10CE7142D2CF

Q37114899-29DB8FF9-9D50-4DD8-92EE-F1BA8EB052AF

Q37114899-3398107E-C634-460C-AAF0-E5312888505E

Q37114899-490C8D24-4FE9-4F87-9A50-47A96E42989C

Q37114899-507BCF1B-1BB5-4976-8F05-FF1B64FAEECE

Q37114899-640CD199-9B45-457D-9154-CFE25D5C51F9

Q37114899-667D6629-92BE-4576-B06C-718953534F9E

Q37114899-77591FF3-1FEA-4528-825A-522658284025

P2888

Q37114899-414457A5-8C63-452E-9D89-B68EEF1AC6A3

P304

Q37114899-88E0441A-54A5-4B50-BF5F-B4EFFA394374

P31

Q37114899-959C1AFD-0D42-401A-B929-AB039A3D7EA0

P356

Q37114899-C9BD37AC-B682-4999-8E70-C520AD37498B

P433

Q37114899-04F97F3D-BE79-439B-8F32-F465EAD83E19

P478

Q37114899-94EFF12E-EDAF-4F5B-A64F-F0414D049D96

P577

Q37114899-F0A725FF-897B-4F27-8D62-BEB2DD92707D

P5875

Q37114899-56271C00-93F7-4C07-A8FA-E2D9F1FDEAED

P6179

Q37114899-BBD65F09-3F08-46BC-B22F-478C3FC11FB4

P698

Q37114899-C6E2046D-45EF-4C2A-8BC4-D4D17AA14048

P932

Q37114899-34E0585D-3E51-4FA0-A794-87EA21D8EA5C

P356

1756-9966-32-50

P1433

Journal of Experimental & Clinical Cancer Research

P1476

Detection of EGFR mutations in circulating free DNA by PNA-mediated PCR clamping.

@en

P2093

Chang-Min Choi

http://www.w3.org/2001/XMLSchema#string

Dae-Sung Hyun

http://www.w3.org/2001/XMLSchema#string

Hye-Ryoun Kim

http://www.w3.org/2001/XMLSchema#string

Hyun-Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Jae Cheol Lee

http://www.w3.org/2001/XMLSchema#string

Kye Young Lee

http://www.w3.org/2001/XMLSchema#string

Min Ki Lee

http://www.w3.org/2001/XMLSchema#string

Sei-Hoon Yang

http://www.w3.org/2001/XMLSchema#string

Seung Hun Jang

http://www.w3.org/2001/XMLSchema#string

Sun Young Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Detection of mutations in EGFR in circulating lung-cancer cells

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release.

A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screening.

Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours.

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas.

A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer.

Rapid detection of epidermal growth factor receptor mutations in non-small cell lung cancer using real-time polymerase chain reaction with TaqMan-MGB probes.

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).

P2888

1756-9966-32-50

P304

50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-9966-32-50

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255714160

http://www.w3.org/2001/XMLSchema#string

P6179

1033191206

http://www.w3.org/2001/XMLSchema#string

P698

23927790

http://www.w3.org/2001/XMLSchema#string

P932

3751150

http://www.w3.org/2001/XMLSchema#string